StrandAdvantage test for early‐line and advanced‐stage treatment decisions in solid tumors

Comprehensive genetic profiling of tumors using next‐generation sequencing (NGS) is gaining acceptance for guiding treatment decisions in cancer care. We designed a cancer profiling test combining both deep sequencing and immunohistochemistry (IHC) of relevant cancer targets to aid therapy choices i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Manimala, Katragadda, Shanmukh, Ravichandran, Aarthi, Deshpande, Gouri, Parulekar, Minothi, Nayanala, Swetha, Vittal, Vikram, Shen, Weiming, Phooi Nee Yong, Melanie, Jacob, Jemima, Parchuru, Sravanthi, Dhanuskodi, Kalpana, Eyring, Kenneth, Agrawal, Pooja, Agarwal, Smita, Shanmugam, Ashwini, Gupta, Satish, Vishwanath, Divya, Kumari, Kiran, Hariharan, Arun K., Balaji, Sai A., Liang, Qiaoling, Robolledo, Belen, Gauribidanur Raghavendrachar, Vijayashree, Oomer Farooque, Mohammed, Buresh, Cary J., Ramamoorthy, Preveen, Bahadur, Urvashi, Subramanian, Kalyanasundaram, Hariharan, Ramesh, Veeramachaneni, Vamsi, Sankaran, Satish, Gupta, Vaijayanti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430095/
https://www.ncbi.nlm.nih.gov/pubmed/28371134
http://dx.doi.org/10.1002/cam4.1037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430095/
https://www.ncbi.nlm.nih.gov/pubmed/28371134
http://dx.doi.org/10.1002/cam4.1037

Ejemplares similares